Prognostic value of 18F-FDG PET/MRI in patients with advanced oropharyngeal and hypopharyngeal squamous cell carcinoma

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1864-6433
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Prognostic value of 18F-FDG PET/MRI in patients with advanced oropharyngeal and hypopharyngeal squamous cell carcinoma ; volume:35 ; number:4 ; day:11 ; month:2 ; year:2021 ; pages:479-484 ; date:4.2021
Annals of nuclear medicine ; 35, Heft 4 (11.2.2021), 479-484, 4.2021

Creator
Pace, Leonardo
Nicolai, Emanuele
Cavaliere, Carlo
Basso, Luca
Garbino, Nunzia
Spinato, Giacomo
Salvatore, Marco
Contributor
SpringerLink (Online service)

DOI
10.1007/s12149-021-01590-y
URN
urn:nbn:de:101:1-2021050616391553291408
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:57 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Pace, Leonardo
  • Nicolai, Emanuele
  • Cavaliere, Carlo
  • Basso, Luca
  • Garbino, Nunzia
  • Spinato, Giacomo
  • Salvatore, Marco
  • SpringerLink (Online service)

Other Objects (12)

[18F]FDG PET/MRI in rectal cancer

[18F]FDG PET/MRI in rectal cancer

18F-FDG PET/MRI in adult sarcomas

18F-FDG PET/MRI in adult sarcomas

Ultra-low-dose in brain 18F-FDG PET/MRI in clinical settings

Ultra-low-dose in brain 18F-FDG PET/MRI in clinical settings

[18F]FDG PET/MRI enables early chemotherapy response prediction in pancreatic ductal adenocarcinoma

[18F]FDG PET/MRI enables early chemotherapy response prediction in pancreatic ductal adenocarcinoma

AI-enhanced simultaneous multiparametric 18F-FDG PET/MRI for accurate breast cancer diagnosis

AI-enhanced simultaneous multiparametric 18F-FDG PET/MRI for accurate breast cancer diagnosis

[18F]FDG PET/MRI enables early chemotherapy response prediction in pancreatic ductal adenocarcinoma

[18F]FDG PET/MRI enables early chemotherapy response prediction in pancreatic ductal adenocarcinoma

Impact of attenuation correction on clinical [18F]FDG brain PET in combined PET/MRI

Impact of attenuation correction on clinical [18F]FDG brain PET in combined PET/MRI

18F-FDG Brain PET/MRI in Amyotrophic Lateral Sclerosis– Frontotemporal Spectrum Disorder (ALS-FTSD)

18F-FDG Brain PET/MRI in Amyotrophic Lateral Sclerosis– Frontotemporal Spectrum Disorder (ALS-FTSD)

Impact of attenuation correction on clinical [18F]FDG brain PET in combined PET/MRI

Impact of attenuation correction on clinical [18F]FDG brain PET in combined PET/MRI

Diagnostic value of [18F]FDG PET/MRI for staging in patients with ovarian cancer

Diagnostic value of [18F]FDG PET/MRI for staging in patients with ovarian cancer

Initial experience in staging primary oesophageal/gastro-oesophageal cancer with 18F-FDG PET/MRI

Initial experience in staging primary oesophageal/gastro-oesophageal cancer with 18F-FDG PET/MRI

Diagnostic performance of prospective same-day 18F-FDG PET/MRI and 18F-FDG PET/CT in the staging and response assessment of lymphoma

Diagnostic performance of prospective same-day 18F-FDG PET/MRI and 18F-FDG PET/CT in the staging and response assessment of lymphoma

Related objects